AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
-6.65%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$1.97B
AUM Growth
+$1.97B
(-21%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-12.97%
Top 10 Holdings %
Top 10 Hldgs %
88.61%
Holding
44
New
1
Increased
1
Reduced
3
Closed
2
Top Buys
| 1 |
TEM
Tempus AI, Inc. Class A Common Stock
TEM
|
$54.3M |
| 2 |
Revolution Medicines
RVMD
|
$216K |
Top Sells
| 1 |
CrowdStrike
CRWD
|
$164M |
| 2 |
DexCom
DXCM
|
$85.5M |
| 3 |
DM
Desktop Metal, Inc.
DM
|
$41.1M |
| 4 |
Invivyd
IVVD
|
$20.1M |
| 5 |
MOND
Mondee Holdings, Inc. Class A Common Stock
MOND
|
$42.6K |
Sector Composition
| 1 | Technology | 65.24% |
| 2 | Healthcare | 31.4% |
| 3 | Industrials | 3.24% |
| 4 | Consumer Staples | 0.12% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
GitLab
GTLB
$7.93B
| $485M | 24.58% | 9,758,333 | – | – |
|
2
Arm
ARM
$147B
| $321M | 16.25% | 1,960,784 | – | – |
|
|
3
Revolution Medicines
RVMD
$7.1B
| $206M | 10.43% | 5,307,075 +5,563 | +0.1% | +$216K |
|
|
4
CrowdStrike
CRWD
$106B
| $164M | 8.31% | 427,895 -427,894 | -50% | -$164M |
|
5
Freshworks
FRSH
$3.93B
| $157M | 7.93% | 12,336,643 | – | – |
|
|
6
DexCom
DXCM
$29.5B
| $118M | 5.96% | 1,036,937 -753,836 | -42% | -$85.5M |
|
7
UiPath
PATH
$5.95B
| $89.2M | 4.52% | 7,034,337 | – | – |
|
8
Prime Medicine
PRME
$578M
| $77.4M | 3.92% | 15,062,498 | – | – |
|
9
Snowflake
SNOW
$79.6B
| $72.4M | 3.66% | 535,604 | – | – |
|
|
VERV
10
DELISTED
Verve Therapeutics
VERV
| $60.3M | 3.05% | 12,349,086 | – | – |
|
11
Planet Labs
PL
$2.15B
| $59.4M | 3.01% | 31,942,641 | – | – |
|
|
TEM
12
Tempus AI, Inc. Class A Common Stock
TEM
$13.2B
| $54.3M | 2.75% | +1,551,102 | New | +$54.3M |
|
13
Sana Biotechnology
SANA
$777M
| $15.4M | 0.78% | 2,812,500 | – | – |
|
14
Relay Therapeutics
RLAY
$619M
| $10.2M | 0.52% | 1,568,753 | – | – |
|
15
Vera Therapeutics
VERA
$1.38B
| $8.73M | 0.44% | 241,264 | – | – |
|
16
Lyell Immunopharma
LYEL
$213M
| $8.5M | 0.43% | 5,865,125 | – | – |
|
17
Oscar Health
OSCR
$4.31B
| $7.63M | 0.39% | 481,988 | – | – |
|
18
Beam Therapeutics
BEAM
$1.66B
| $7.54M | 0.38% | 321,604 | – | – |
|
19
TScan Therapeutics
TCRX
$102M
| $6.3M | 0.32% | 1,077,080 | – | – |
|
20
Illumina
ILMN
$15.8B
| $5.58M | 0.28% | 53,470 | – | – |
|
21
Monte Rosa Therapeutics
GLUE
$296M
| $5.48M | 0.28% | 1,464,015 | – | – |
|
22
Dianthus Therapeutics
DNTH
$759M
| $5.4M | 0.27% | 208,697 | – | – |
|
|
DM
23
DELISTED
Desktop Metal, Inc.
DM
| $4.56M | 0.23% | 1,104,871 -9,943,859 | -90% | -$41.1M |
|
24
Foghorn Therapeutics
FHTX
$286M
| $2.88M | 0.15% | 500,901 | – | – |
|
25
Tenaya Therapeutics
TNYA
$184M
| $2.84M | 0.14% | 915,705 | – | – |
|